Filing Details
- Accession Number:
- 0001209191-16-137786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-18 16:49:48
- Reporting Period:
- 2016-08-16
- Filing Date:
- 2016-08-18
- Accepted Time:
- 2016-08-18 16:49:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286125 | W Charles Olson | 9924 West 74Th Street Eden Prairie MN 55344 | Senior Vp & Gm, Med Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-08-16 | 4,383 | $29.18 | 33,098 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-16 | 1,528 | $29.02 | 31,570 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-17 | 1,000 | $29.00 | 30,570 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-17 | 2,000 | $28.65 | 28,570 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-17 | 1,025 | $28.67 | 27,545 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 800 | Indirect | By IRA |
Footnotes
- Reflects the weighted average price of 4,383 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 16, 2016 with sale prices ranging from $29.10 to $29.39 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 1,528 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 16, 2016 with sale prices ranging from $29.00 to $29.043 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 2,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 17, 2016 with sale prices ranging from $28.55 to $29.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 1,025 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 17, 2016 with sale prices ranging from $28.51 to $28.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
